Why the study?
Some specific fish peptides have anti-hypertensive effects, leading authors to test whether the hexapeptide MEVFVP from flounder fish muscle functions as a potent antihypertensive peptide.
Does oral administration of the hexapeptide MEVFVP reduce blood pressure in spontaneously hypertensive rats?
Does oral administration of the hexapeptide MEVFVP reduce blood pressure in spontaneously hypertensive rats?
The flounder fish hexapeptide MEVFVP demonstrates acute antihypertensive effects in a rat model by modulating the renin-angiotensin-aldosterone system and endothelin-1.
Answers are grounded in this paper and cite their sources.
Supports preclinical testing of fish peptides; leaves open clinical translation in hypertension.
BACKGROUND: Many fishes have been known for their good nutritional effects especially in the cardiovascular aspect. Some specific fish peptides have anti-hypertensive effects. OBJECTIVE: In the present study, we hypothesized that the hexapeptide (MEVFVP) from flounder fish muscle can be a potent antihypertensive peptide, therefore, decided to perform this experiment. METHODS: The peptide MEVFVP from flounder fish muscle (40 mg/kg) and vehicle were administered per os to spontaneously hypertensive rats (SHRs) (SHR-M and SHR-C, respectively). Additionally, plasma MEVFVP was measured serially before and after its oral administration to Sprague Dawley rats. RESULTS: Blood pressures (BPs), especially systolic BP, in SHR rats were decreased around 3-6 hours after MEVFVP administration. Compared with SHR-C rats, endothelin-1 (ET-1) mRNA expression in multiple tissues, and plasma levels of ET-1, angiotensin II, and aldosterone were lower in SHR-M rats, whereas the phosphorylation of AMP-activated protein kinase (AMPK) was increased in the kidney of SHR-M rats. The administered peptide was not detected in rat plasma, while ex vivo incubation of the peptide in rat plasma caused its rapid degradation within minutes. CONCLUSION: Our results show that the MEVFVP has an antihypertensive effect by regulating renin- angiotensin-aldosterone system, ET-1 and AMPK despite its limited bioavailability.
No takes yet. Share an insight, caveat, or question.
Rahmdel et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: